Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives.
MRI-LINAC
PSMA
brachytherapy
external beam radiotherapy
hypofractionation
mp-MRI
prostate cancer
proton beam radiotherapy
stereotactic body radiotherapy
ultrahypofractionation
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
26
04
2023
revised:
10
06
2023
accepted:
12
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically localized form of the disease, with most of them presenting with low- or intermediate-risk prostate cancer. In this setting, various curative-intent alternatives are available, including surgery, external beam radiotherapy and brachytherapy. Randomized clinical trials have demonstrated that moderate hypofractionated radiotherapy can be considered as a valid alternative strategy for localized prostate cancer. High-dose-rate brachytherapy can be administered according to different schedules. Proton beam radiotherapy represents a promising strategy, but further studies are needed to make it more affordable and accessible. At the moment, new technologies such as MRI-guided radiotherapy remain in early stages, but their potential abilities are very promising.
Identifiants
pubmed: 37374348
pii: medicina59061144
doi: 10.3390/medicina59061144
pmc: PMC10301277
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Urology. 2019 Aug;130:1-12
pubmed: 30986486
Br J Radiol. 2021 Aug 01;94(1124):20210242
pubmed: 34282946
Prostate Int. 2022 Jun;10(2):80-84
pubmed: 35510080
Acta Clin Croat. 2022 Oct;61(Suppl 3):65-70
pubmed: 36938552
Adv Radiat Oncol. 2021 Jan 16;6(3):100647
pubmed: 33748548
Radiother Oncol. 2013 Nov;109(2):217-21
pubmed: 24060175
Eur Urol. 2017 Nov;72(5):689-709
pubmed: 28189428
Surg Oncol Clin N Am. 2017 Jul;26(3):491-513
pubmed: 28576185
Lancet Oncol. 2016 Aug;17(8):1047-1060
pubmed: 27339115
Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1082-1089
pubmed: 33539968
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1026-32
pubmed: 15519771
J Med Imaging Radiat Oncol. 2021 Jun;65(3):384-397
pubmed: 33855816
Arch Ital Urol Androl. 2022 Jun 29;94(2):166-168
pubmed: 35775340
J Clin Oncol. 2016 Jul 10;34(20):2325-32
pubmed: 27044935
Eur Urol Open Sci. 2020 Oct 23;22:9-16
pubmed: 34337473
Curr Urol Rep. 2019 Jul 29;20(9):53
pubmed: 31359187
Phys Med Biol. 2018 Dec 19;64(1):01TR01
pubmed: 30523903
Lancet. 2019 Aug 3;394(10196):385-395
pubmed: 31227373
JAMA Oncol. 2018 Jun 14;4(6):e180039
pubmed: 29543933
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):657-66
pubmed: 26797541
Cancers (Basel). 2022 Mar 23;14(7):
pubmed: 35406385
Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):713-722
pubmed: 31199994
Eur Urol Oncol. 2018 Dec;1(6):540-547
pubmed: 31158102
Onco Targets Ther. 2019 Feb 15;12:1259-1268
pubmed: 30863093
Urol Oncol. 2020 Jun;38(6):600.e1-600.e8
pubmed: 31953005
Lancet Oncol. 2022 Oct;23(10):1308-1320
pubmed: 36113498
Cancer Treat Rev. 2016 Feb;43:104-12
pubmed: 26827698
Cancer Biother Radiopharm. 2005 Feb;20(1):47-51
pubmed: 15778580
Crit Rev Oncol Hematol. 2021 Sep;165:103432
pubmed: 34352361
Lancet. 2022 May 14;399(10338):1886-1901
pubmed: 35569466
J Urol. 2019 Sep;202(3):533-538
pubmed: 31042111
J Contemp Brachytherapy. 2022 Oct;14(5):481-494
pubmed: 36478697
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):675-82
pubmed: 26238951
J Med Imaging Radiat Oncol. 2019 Dec;63(6):829-835
pubmed: 31486267
Radiother Oncol. 2016 Jun;119(3):411-6
pubmed: 27118583
Acta Oncol. 2017 Jul;56(7):963-970
pubmed: 28514929
Biomedicines. 2022 Sep 30;10(10):
pubmed: 36289708
Transl Androl Urol. 2017 Feb;6(1):134-136
pubmed: 28217463
Lancet Oncol. 2015 Mar;16(3):274-83
pubmed: 25656287
Br J Radiol. 2022 Mar 1;95(1131):20210800
pubmed: 35073158
Nat Rev Urol. 2021 Nov;18(11):669-685
pubmed: 34389825
Semin Radiat Oncol. 2008 Oct;18(4):240-3
pubmed: 18725110
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
Lancet Oncol. 2019 Nov;20(11):1531-1543
pubmed: 31540791
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):871-873
pubmed: 29485065
Indian J Urol. 2015 Jul-Sep;31(3):194-201
pubmed: 26166962
BJU Int. 2014 Mar;113 Suppl 2:7-12
pubmed: 24894850
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1038-1044
pubmed: 30771408
Radiat Oncol. 2014 Dec 06;9:275
pubmed: 25480014
Arch Ital Urol Androl. 2022 Sep 26;94(3):274-277
pubmed: 36165469
Crit Rev Oncol Hematol. 2022 May;173:103661
pubmed: 35341986
Front Oncol. 2023 Jan 13;12:1077900
pubmed: 36713508
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
pubmed: 20610543
J Clin Oncol. 2021 Mar 1;39(7):787-796
pubmed: 33471548
Front Oncol. 2021 Aug 26;11:701998
pubmed: 34513681
Radiother Oncol. 2019 Jun;135:86-90
pubmed: 31015175
Nuklearmedizin. 2017 Aug 14;56(4):147-155
pubmed: 28715042
J Clin Oncol. 2014 Sep 10;32(26):2855-63
pubmed: 25113772
J Clin Oncol. 2010 Mar 1;28(7):1106-11
pubmed: 20124169
Curr Oncol Rep. 2017 Apr;19(4):30
pubmed: 28343352
Clin Transl Radiat Oncol. 2023 Mar 17;40:100612
pubmed: 36992969
Cancers (Basel). 2022 Jan 29;14(3):
pubmed: 35158961
J Clin Med. 2022 Jun 16;11(12):
pubmed: 35743547
Acta Oncol. 2018 Jul;57(7):883-894
pubmed: 29405785
J Clin Med. 2022 May 12;11(10):
pubmed: 35628867
Trials. 2023 Mar 6;24(1):167
pubmed: 36879271
Eur Urol. 2014 Dec;66(6):1024-30
pubmed: 24985964
Lancet Oncol. 2021 Feb;22(2):235-245
pubmed: 33444529
Radiother Oncol. 2020 Jun;147:92-98
pubmed: 32247206
Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1021-31
pubmed: 11429230
Anticancer Res. 2013 Jun;33(6):2785-9
pubmed: 23749942
J Clin Oncol. 2017 Jun 10;35(17):1884-1890
pubmed: 28296582
JAMA Netw Open. 2022 Jul 1;5(7):e2223025
pubmed: 35900763
J Clin Oncol. 2018 Oct 11;:JCO1801097
pubmed: 30307776
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Lancet Oncol. 2020 Oct;21(10):1341-1352
pubmed: 33002438
Strahlenther Onkol. 2021 Feb;197(2):89-96
pubmed: 33301049
Lancet. 2020 Oct 31;396(10260):1413-1421
pubmed: 33002429
Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1095-101
pubmed: 10192361
Br J Radiol. 1989 Aug;62(740):679-94
pubmed: 2670032
Radiother Oncol. 2019 Oct;139:83-86
pubmed: 31431369
Lancet Oncol. 2016 Aug;17(8):1061-1069
pubmed: 27339116
Trials. 2021 Oct 21;22(1):728
pubmed: 34674739
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74
pubmed: 17765406
Radiother Oncol. 2021 Jun;159:146-154
pubmed: 33775715
Radiother Oncol. 2018 Feb;126(2):257-262
pubmed: 29103826
Technol Cancer Res Treat. 2016 Feb;15(1):179-85
pubmed: 25586517
J Urol. 2003 Feb;169(2):517-23
pubmed: 12544300